Coverage dated January 30, 2022 to February 4, 2022
CDC Backs Full Approval of Moderna COVID Vaccine
Headline from Madison, on the newest of 2 developments
FRIDAY, Feb. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Friday gave its full approval to Moderna's COVID-19 vaccine for use in people 18
Madison's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
CDC recommends FDA-approved Moderna COVID-19 vaccine for adults
MONDAY, Jan. 31, 2022 (HealthDay News) -- Moderna's COVID-19 vaccine has received full approval for use in people 18 and older, the U.S. Food and Drug Administration announced Monday.
WASHINGTON (AP) — U.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given to tens of millions of Americans since its emergency
By Naomi Thomas and Ben Tinker, CNN Moderna’s Covid-19 vaccine has received full approval from the US Food and Drug Administration, according to news releases from the FDA and Moderna. The vaccine, named Spikevax, is now approved for use in people ages 18 and older.
The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's Covid-19 "Spikevax" vaccine, which had previously received an emergency use authorization in…
Approval based on a comprehensive submission package including efficacy and safety data approximately six months after second doseSPIKEVAX has received
WASHINGTON — Moderna announced Monday that U.S. health regulators granted full approval to its covid-19 vaccine, a shot that’s been given to tens of millions of Americans since its emergency authorization over a year ago.
Moderna’s COVID-19 vaccine became the second to receive FDA approval on Jan. 31, 2022. Meanwhile, the FDA approved Pfizer’s COVID-19 vaccine on Aug. 23, 2021.
MONDAY, Jan. 31, 2022 (HealthDay News) -- The Moderna COVID-19 vaccine has received full approval for use in people 18 years and older, the U.S. Food and Drug Administration announced
On Monday, the U.S. Food and Drug Administration (FDA) granted its full approval to Moderna’s Wuhan coronavirus vaccine for adults ages 18 and older. The vaccine has been available under
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — A federal advisory panel has voted to continue to endorse Moderna’s COVID-19 vaccine for U.S. adults. The Advisory Committee on Immunization Practices voted unanimously to continue to recommend the two-dose primary series.
NEW YORK (AP) — The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots
By Jamie Gumbrecht and Carma Hassan, CNN Vaccine advisers to the US Centers for Disease Control and Prevention voted 13-0 Friday to support recommending the two-dose Moderna Covid-19 vaccine, which received full approval from the US Food and Drug Administration earlier this week for use in adults.
A federal advisory panel voted unanimously Friday to continue to endorse Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval.
NEW YORK (AP) — The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots their fu
Moderna applied for emergency approval of its Covid vaccine for 12- to 17-year-olds in June, but the FDA said its review wouldn’t be completed before January.
FRIDAY, Feb. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Friday gave its full approval to Moderna's COVID-19 vaccine for use in people 18
Showing the first 25 of 27 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
CDC Backs Full Approval of Moderna COVID Vaccine | Since Then
